Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 4, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
Bayer and Evotec form a new strategic alliance focusing on the treatment of polycystic ovary syndrome
admin
-
January 13, 2020
0
Latest Pharma-News
Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine
admin
-
January 10, 2020
0
Latest Pharma-News
Hikma and Arecor announce exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US using Arestat™ technology
admin
-
January 10, 2020
0
Latest Pharma-News
Bayer and Exscientia collaborate to influence the potential of artificial intelligence(AI) in cardiovascular and oncology drug discovery
admin
-
January 10, 2020
0
Latest Pharma-News
FDA approves Blueprint Medicines Ayvakit (avapritinib) ,first targeted therapy to treat a rare mutation in patients with Unresectable or Metastatic PDGFRA Exon 18...
admin
-
January 10, 2020
0
Latest Pharma-News
Daiichi Sankyo ENHERTU® is Now Available in the U.S. for the HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based...
admin
-
January 9, 2020
0
Latest Pharma-News
FDA approves less invasive surgical approach for Abbott’s heart pump in order to help patients avoid Open Heart Surgery
admin
-
January 9, 2020
0
Latest Pharma-News
Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility does not improve pregnancy rates, sperm counts or sperm function
admin
-
January 9, 2020
0
Latest Pharma-News
BMS Completes Divestment of its oral solid, biologics, and sterile product Manufacturing and packaging Facility in Anagni, Italy
admin
-
January 9, 2020
0
Latest Pharma-News
FDA Ok’s Teleflex for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
admin
-
January 8, 2020
0
Latest Pharma-News
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
admin
-
January 8, 2020
0
Latest Pharma-News
BAVENCIO (avelumab) extensively Improved Overall Survival in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
admin
-
January 8, 2020
0
1
...
133
134
135
...
144
Page 134 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024